12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Nexalin Technology (NASDAQ:NXL) stock increased by 47.9% to $2.81 during Tuesday’s regular session. The market value of…
Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol
Verve Therapeutics' latest update on the Heart-1 Phase 1b trial of VERVE-101. Explore VERVE-102's development and regulatory clearances for the Heart-2 clinical trial, offering hope for patients with cardiovascular conditions.
Crude Oil Surges Over 1%; US Factory Orders Increase In February
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday.
The Dow traded down 1.05% to 39,152.47 while the NASDAQ fell 1.17% to 16,205.37. The S&P 500 also fell, dropping, 0.89% to 5,196.96.
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers MSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday’s pre-market session. The company’s market cap…
Verve Therapeutics Announces Updates On PCSK9 Program, Company To Pause Enrollment In Heart-1 Clinical Trial Following Asymptomatic Grade 3 Transient Alt Elevation And Thrombocytopenia Seen In Sixth Participant Enrolled In 0.45 Mg/Kg Dose Cohort
VERVE-101 is being evaluated in the Heart-1 Phase 1b clinical trial with trial endpoints of safety and tolerability as well as changes in blood PCSK9 protein and low-density lipoprotein cholesterol (LDL-C) levels in
$18M Bet On Verve Therapeutics? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.
Why Verve Therapeutics Stock (VERV) Is Falling
Verve Therapeutics Inc (NASDAQ: VERV) shares are trading lower by 6.3% to $11.18 Wednesday morning after the company priced its proposed public offering of common stock and
Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Shares of Workday, Inc. (NASDAQ: WDAY) surged in pre-market trading after the company reported upbeat earnings results for its third quarter.
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Vivos Therapeutics (NASDAQ:VVOS) shares moved upwards by 132.6% to $10.21 during Wednesday’s pre-market session. The company’s market…